Company Description
Novartis AG. The Group's principal activity is the development and manufacture of pharmaceuticals and nutritional products. The Group operates through four divisions; Pharmaceuticals, Consumer Health, Sandoz & Vaccines & Diagnostics. Pharmaceuticals ...
More
Related Business Topics
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
N
Novartis AG
Discovers, develops, manufactures and markets arthritis, inflammation, bone, cardiovascular, metabolic, dermatology, hematology, neuroscience, and oncology drugs.
www.novartis.com
Discovers, develops, manufactures and markets arthritis, inflammation, bone, cardiovascular, metabolic, dermatology, hematology, neuroscience, and oncology drugs.
www.novartis.com
Breaking News
Reuters India - July 02, 2009 6:48 PM
By Julie Steenhuysen CHICAGO (Reuters) - Drugs used to treat Parkinson's disease show promise as a new way to stem the rise of drug-resistant forms of tuberculosis, U.S. researchers said on Thursday. They said computer models and lab experiments suggest ...
Forbes.com - July 02, 2009 6:45 PM
CHICAGO, July 2 (Reuters) - Drugs used to treat Parkinson's disease show promise as a new way to stem the rise of drug-resistant forms of tuberculosis, U.S. researchers said on Thursday. They said computer models and lab experiments suggest the drugs ...
Reuters UK - July 02, 2009 5:39 PM
By Julie Steenhuysen CHICAGO (Reuters) - Drugs used to treat Parkinson's disease show promise as a new way to stem the rise of drug-resistant forms of tuberculosis, U.S. researchers said on Thursday. They said computer models and lab experiments suggest ...
Reuters - July 02, 2009 5:32 PM
* Drugs could be used to fight dangerous forms of TB * Compounds already proven in humans CHICAGO, July 2 (Reuters) - Drugs used to treat Parkinson's disease show promise as a new way to stem the rise of drug-resistant forms of tuberculosis, U.S. ...
Reuters - July 02, 2009 11:42 AM
* Lucentis improved sight in retinal vein occlusion * Condition causes vision to cloud ZURICH, July 2 (Reuters) - Monthly injections of Lucentis can significantly improve sight in people with retinal vein occlusion, which leads to vision loss, according ...
Find Free Prescriptions
Prescription Assistance Programs Annual Income under $42k to Join
www.myrxadvocate.com
Prescription Assistance Programs Annual Income under $42k to Join
www.myrxadvocate.com
Careers at Abbott
Work in a dynamic environment that inspires innovation.
www.AbbottInCalifornia.com
Work in a dynamic environment that inspires innovation.
www.AbbottInCalifornia.com
Pfizer Pharmaceutical
Morningstar provides a Free Report: "Healthcare Sector and the Economy"
healthcare.morningstar.com
Morningstar provides a Free Report: "Healthcare Sector and the Economy"
healthcare.morningstar.com
